BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25705034)

  • 41. Overview of quantitative LC-MS techniques for proteomics and activitomics.
    Timms JF; Cutillas PR
    Methods Mol Biol; 2010; 658():19-45. PubMed ID: 20839096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular vesicles: An overview of biogenesis, function, and role in breast cancer.
    Zha QB; Yao YF; Ren ZJ; Li XJ; Tang JH
    Tumour Biol; 2017 Feb; 39(2):1010428317691182. PubMed ID: 28231725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
    Xu R; Greening DW; Rai A; Ji H; Simpson RJ
    Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of extracellular vesicles by IR spectroscopy: Fast and simple classification based on amide and CH stretching vibrations.
    Mihály J; Deák R; Szigyártó IC; Bóta A; Beke-Somfai T; Varga Z
    Biochim Biophys Acta Biomembr; 2017 Mar; 1859(3):459-466. PubMed ID: 27989744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE; Lane L
    Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.
    Coleman BM; Hill AF
    Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass spectrometry-based proteomics in the life sciences.
    Lane CS
    Cell Mol Life Sci; 2005 Apr; 62(7-8):848-69. PubMed ID: 15868409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology.
    Pfeifer P; Werner N; Jansen F
    Biomed Res Int; 2015; 2015():161393. PubMed ID: 26558258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical proteomics: current status, challenges, and future perspectives.
    Chiou SH; Wu CY
    Kaohsiung J Med Sci; 2011 Jan; 27(1):1-14. PubMed ID: 21329886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomics unravels extracellular vesicles as carriers of classical cytoplasmic proteins in Candida albicans.
    Gil-Bona A; Llama-Palacios A; Parra CM; Vivanco F; Nombela C; Monteoliva L; Gil C
    J Proteome Res; 2015 Jan; 14(1):142-53. PubMed ID: 25367658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Optimized Procedure for Proteomic Analysis of Extracellular Vesicles Using In-Stage Tip Digestion and DIA LC-MS/MS: Application to Liquid Biopsy in Cancer.
    Soni RK; Dimapanat L; Katari MS; Rai AJ
    Methods Mol Biol; 2022; 2546():401-409. PubMed ID: 36127607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular vesicles as new pharmacological targets to treat atherosclerosis.
    Yin M; Loyer X; Boulanger CM
    Eur J Pharmacol; 2015 Sep; 763(Pt A):90-103. PubMed ID: 26142082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
    Zhao YY; Lin RC
    Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
    Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MS/MS-based strategies for proteomic profiling of invasive cell structures.
    Havrylov S; Park M
    Proteomics; 2015 Jan; 15(2-3):272-86. PubMed ID: 25303514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Approaches and applications of quantitative LC-MS for proteomics and activitomics.
    Cutillas PR; Timms JF
    Methods Mol Biol; 2010; 658():3-17. PubMed ID: 20839095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of extracellular vesicles for proteomic profiling.
    Choi DS; Gho YS
    Methods Mol Biol; 2015; 1295():167-77. PubMed ID: 25820722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research.
    Kim DK; Lee J; Simpson RJ; Lötvall J; Gho YS
    Semin Cell Dev Biol; 2015 Apr; 40():4-7. PubMed ID: 25704310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative analysis of highly homologous proteins: the challenge of assaying the "CYP-ome" by mass spectrometry.
    Langenfeld E; Meyer HE; Marcus K
    Anal Bioanal Chem; 2008 Nov; 392(6):1123-34. PubMed ID: 18846368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.